Diabetes prevalence and diagnosis in US states: Analysis of health surveys

Population Health Metrics

Volumn 7, Issue , 2009, Pages 16-

  Danaei, Goodarz ^a,b   Friedman, Ari B ^b   Oza, Shefali ^b   Murray, Christopher J L ^c   Ezzati, Majid ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Harvard Initiative for Global Health   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DIABETES MELLITUS; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH INSURANCE; HEALTH SURVEY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; UNITED STATES;

EID: 70449511788     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/1478-7954-7-16     Document Type: Article

References (20)

1. Murray CJ, Dias RH, Kulkarni SC, Lozano R, Stevens GA, Ezzati M. Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care 2008, 31:451-458. 10.2337/dc07-1370, 17959860.
2. Ezzati M, Martin H, Skjold S, Vander HS, Murray CJ. Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med 2006, 99:250-257. 10.1258/jrsm.99.5.250, 1457748, 16672759.
3. Centers for Disease Control and Prevention NCfHS National Health and Nutrition Examination Survey data sets and related documentation (Survey Questionnaire, Examination and Laboratory Protocols, 1988-1994 and 1999-2002). 2002,
4. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294. 10.2337/dc08-1296, 19017771.
5. Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed 2001, 46(Suppl 1):S3-42.
6. Remington PL, Smith MY, Williamson DF, Anda RF, Gentry EM, Hogelin GC. Design, characteristics, and usefulness of state-based behavioral risk factor surveillance: 1981-87. Public Health Rep 1988, 103:366-375. 1478092, 2841712.
7. Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Am J Nurs 2004, 104:83-90. 15108576.
8. Danaei G, Lawes CM, Vander HS, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-thanoptimum blood glucose concentration: comparative risk assessment. Lancet 2006, 368:1651-1659. 10.1016/S0140-6736(06)69700-6, 17098083.
9. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001, 345:790-797. 10.1056/NEJMoa010492, 11556298.
10. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 2005, 353:692-700. 10.1056/NEJMsa051207, 16107622.
11. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001, 161:1542-1548. 10.1001/archinte.161.12.1542, 11427103.
12. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003, 289:1785-1791. 10.1001/jama.289.14.1785, 12684356.
13. Wannamethee SG, Camargo CA, Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med 2003, 163:1329-1336. 10.1001/archinte.163.11.1329, 12796069.
14. Hu FB, van Dam RM, Liu S. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001, 44:805-817. 10.1007/s001250100547, 11508264.
15. Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003, 138:215-229.
16. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853. 10.1016/S0140-6736(98)07019-6, 9742976.
17. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998, 317:703-713. 28659, 9732337.
18. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, . CARDS investigators Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004, 364:685-696. 10.1016/S0140-6736(04)16895-5, 15325833.
19. Ezzati M, Oza S, Danaei G, Murray CJ. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation 2008, 117:905-914. 10.1161/CIRCULATIONAHA.107.732131, 18268146.
20. Murray CJ, Kulkarni SC, Ezzati M. Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation 2006, 113:2071-2081. 10.1161/CIRCULATIONAHA.105.595777, 16636170.